McGavern, Dorian

18 December 2021
1294 Views

Senior Investigator
Viral Immunology and Intravital Imaging Section
NINDS, NIAID
National Institutes of Health (NIH)
Bethesda (MD) | USA

 

Dr. McGavern received his B.S degree in microbiology from The Pennsylvania State University and his Ph.D. in molecular neuroscience from the Mayo Clinic. Following an academic appointment as an Associate Professor in the Department of Immunology and Microbial Sciences at The Scripps Research Institute, Dr. McGavern joined the NINDS in 2009 and NIAID in 2021. Dr. McGavern is the recipient of the Ray Thomas Edwards Foundation Award and the Burroughs Wellcome Fund Pathogenesis of Infectious Disease Award. As Chief of the Viral Immunology and Intravital Imaging Section, Dr. McGavern’s research program at the NIH spans the disciplines of neuroscience, microbiology, and immunology, exploring immune responses to various central nervous system perturbations such as infections (viral, parasites, fungi), injuries (traumatic brain injury, ischemia), tumors, and neurodegeneration. The studies impact directly upon many neurological diseases in humans, including meningitis, encephalitis, cerebral malaria, tauopathy, glioblastoma, stroke, and traumatic brain injury.

You may be interested

ISNI Young Time – August 15 @ 10:00 am EST
News
35 views
News
35 views

ISNI Young Time – August 15 @ 10:00 am EST

stine - 11 August 2022

Join the ISNI Young Time on Monday August 15 @ 10:00 am EST. Here is how to connect and it…

Postdoctoral positions available in neuroimmunology in Calgary, Canada
News
66 views
News
66 views

Postdoctoral positions available in neuroimmunology in Calgary, Canada

stine - 3 August 2022

The laboratory of Dr. Wee Yong (Pubmed: Yong VW or Wee Yong V) at the University of Calgary is recruiting…

ISNIYoung – Get feedback on your work!
News
82 views
News
82 views

ISNIYoung – Get feedback on your work!

stine - 22 July 2022

The ISNI Young Committee is organizing a monthly “ISNI Young Time”. The first meeting is on August 15, 2022. During…